Gowtham Subramanian, Wei Jun Lam, Elizabeth Huiwen Tham, Yik Weng Yew, Kenji Kabashima. Dupilumab (DUPIXENT) for bullous pemphigoid. // Trends in Pharmacological Sciences. – 2026. – DOI: 10.1016/j.tips.2026.05.003. – URL: https://doi.org/10.1016/j.tips.2026.05.003
Gowtham Subramanian, Wei Jun Lam, Elizabeth Huiwen Tham, Yik Weng Yew, & Kenji Kabashima (2026). Dupilumab (DUPIXENT) for bullous pemphigoid. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2026.05.003
Gowtham Subramanian, et al. “Dupilumab (DUPIXENT) for bullous pemphigoid.” Trends in Pharmacological Sciences, 2026. doi:10.1016/j.tips.2026.05.003.
@article{Subramanian2026,
title = {Dupilumab (DUPIXENT) for bullous pemphigoid},
author = {Subramanian, Gowtham and Lam, Wei Jun and Tham, Elizabeth Huiwen and Yew, Yik Weng and Kabashima, Kenji},
journal = {Trends in Pharmacological Sciences},
year = {2026},
doi = {10.1016/j.tips.2026.05.003},
url = {https://doi.org/10.1016/j.tips.2026.05.003}
}